PHOENIX, Ariz. (October 23, 2023) — Vālenz® Health announces that Christina Morrison will join the company October 24 as Chief Financial Officer (CFO). Morrison’s appointment comes as Larry Eisel, who has served as Valenz CFO since 2019, has shared his plans to retire at the end of the year.
In addition to overseeing the financial operations of Valenz, Morrison will play a key role in strategic planning and establishing company goals for sustainable growth. Most recently, she served as CFO with PE GI Solutions, acquired last year by SCA Health.
Previously, Morrison was Senior Vice President of Finance at Aramark, where she led financial planning and analysis, mergers and acquisitions, treasury, and global shared services. She was among the leaders of Aramark’s initial public offering in 2013. Prior executive roles also include Senior Vice President of Business and Financial Planning at Merck & Co., Inc., and Senior Vice President/CFO of Wyeth Pharmaceuticals. She began her career in investment banking and became Managing Director at Alex. Brown & Sons, now Deutsche Bank.
“As the top financial executive for a wide range of organizations, Christina brings tremendous business acumen in financial analyses and mergers and acquisitions,” said Rob Gelb, Chief Executive Officer of Valenz. “With a successful track record leading three different company-wide transformation projects, she will set a very high bar for achieving the profound organizational change that accompanies rapid growth.”
Beyond the traditional roles of controller, treasurer and financial risk manager, Morrison will also be responsible for ensuring agreement and alignment on future mergers and acquisitions.
“I’m thrilled for the opportunity to address the ongoing challenges in health insurance that Valenz has dedicated itself to solving — changing the way the industry works with self-insured employers, improving simplification across the board, and driving a member-friendly experience that still manages costs,” Morrison said. “This is a terrific team that truly has a vision to help its customers and their members thrive.”
Based in the Philadelphia area, Morrison has a Bachelor of Science degree in Economics from The Wharton School at the University of Pennsylvania, and she received her MBA from the Tuck School of Business at Dartmouth College. She is also a highly involved board member for InVivo Therapeutics, Angel Flight East and numerous other organizations.
About Vālenz® Health
Vālenz® Health simplifies the complexity of self-insurance for employers by consolidating health plan solutions on a single platform – the industry-leading Healthcare Ecosystem Optimization Platform. Valenz has deep roots in clinical and member advocacy, alongside decades of expertise in the validation, integrity and accuracy of claims, and a suite of risk affinity solutions. With a steadfast commitment to data transparency and decision enablement, and an omnichannel approach across the healthcare journey, Valenz engages early and often to optimize healthcare for the provider, payer, plan and member, delivering improved cost, quality and outcomes for employers and their members – for smarter, better, faster healthcare. More information is available at valenzhealth.com.